Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Craigavon-based pharmaceutical development company Almac recorded pre-tax profits of £19.2m in 2013, up around 30% on the previous year, it has announced.
read more
Tuesday, September 16, 2014
Almac is named National Champion in the UKTI Award for Innovation category.
read more
Almac is pleased to announce the successful completion of the Knowledge Transfer Partnership (KTP) with Queens University, Belfast to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis ...
read more
As the Industry faces the tightest ever new heavy metal mandates from the FDA, stipulating the control and documentation, where appropriate, of all elemental impurities in drug products, drug substances and excipients, Almac has invested in state of ...
read more
Almac Group has received a $288,000 grant to support a clinical study in Sub-Saharan Africa in efforts to find a treatment for Coronavirus.
read more
Wednesday, February 13, 2013
Almac, leading provider of contract services to the global Pharmaceutical and Biotech industries, will play a key role in delivering industry insight on the topic of Supply Chain Management at this year’s 14th Annual CTS Europe event, taking place 26...
read more
Wednesday, October 05, 2022
Almac Clinical Services announced a new state-of-the-art Cryogenic Service Solution within its Durham, North Carolina campus to support cell and gene therapies.
read more
Almac Group Ltd.’s Diagnostics Business Unit today announced the validated results of the ALM AADx assay, a gene expression test that identifies a subgroup of high grade serous ovarian cancer (HGSOC) patients that have a good prognosis following ...
read more
Friday, December 13, 2013
Almac‘s Enzyme Research and Development team have been recognised at The Irish Laboratory Awards by winning “Laboratory Team of the Year.”
read more
Thursday, September 05, 2013
In a dual announcement Almac Discovery Ltd and Queen’s University, Belfast (QUB) have revealed the launch of a formal working partnership between Almac and the Centre for Cancer Research and Cell Biology (CCRCB) at Queen’s, and a significant ...
read more
The Almac Group Ltd, Is pleased to announce plans to make its ALM AADx assay – a gene expression test developed by its Diagnostics Business Unit – available for clinical use in 2015. Further validation of the test in ovarian cancer is on track for ...
read more
Thursday, August 07, 2025
Almirall and Absci Corporation announced the expansion of their ongoing AI Drug Discovery collaboration with Almirall’s selection of a second target aimed at dermatological indications.
read more
Friday, September 25, 2020
Alnylam and Sharp have announced an agreement for the packaging of Alnylam’s approved RNAi therapeutic in European markets.
read more
Orsini Healthcare Specialty Pharmacy announced that it has been selected by Alnylam Pharmaceuticals, Inc to distribute Onpattro (patisiran) lipid complex injection.
read more
Wednesday, March 04, 2020
Alopexx Oncology has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.
read more